Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 16,200
-20 (-0.12%)
At close: Apr 28, 2026
Cell Biotech Revenue
In the year 2025, Cell Biotech had annual revenue of 53.13B KRW with 6.44% growth. Cell Biotech had revenue of 14.63B in the quarter ending December 31, 2025, with 20.38% growth.
Revenue
53.13B
Revenue Growth
+6.44%
P/S Ratio
2.09
Revenue / Employee
526.00M
Employees
101
Market Cap
110.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.13B | 3.21B | 6.44% |
| Dec 31, 2024 | 49.91B | -3.87B | -7.20% |
| Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
| Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
| Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KoBioLabs | 69.29B |
| TegoScience | 5.94B |
| NovMetaPharma | 1.30B |
| CHA Vaccine Research Institute | 158.62M |
| SunBio,Inc. | 2.17B |
| BIO-FD&C | 19.18B |
| CTCBIO | 123.77B |
| Choong Ang Vaccine Laboratory | 39.19B |